Anthem argues Fortune 500 will not suffer from Cigna deal
By Diane Bartz
WASHINGTON (Reuters) - Anthem Inc (ANTM.N: Quote) and the U.S. Justice Department dug in their heels on Monday in court over whether the lower prices the health insurer expects to negotiate after buying smaller rival Cigna Corp (CI.N: Quote) are an efficiency that benefits customers or an antitrust violation.
In the first phase of what could be a two-stage trial, a lawyer for Anthem argued that the $45-billion deal, which was announced more than a year ago, would create a new, bigger insurer with the power to push down prices that it would pass onto customers.
But the Justice Department argued that any cost cuts would come from Anthem using its clout in the market to force hospitals and doctors to work for less.
"Efficiencies don't count if the only way you get them is more market power," the Justice Department's attorney Jon Jacobs said in opening statements.
Judge Amy Berman Jackson of the U.S. District Court for the District of Columbia may opt to block the proposed deal if she decides it will mean higher prices for consumers or that it hurts suppliers. The Justice Department asked her to declare the deal illegal under antitrust law.
The Justice Department's Jacobs argued that the deal would also lead to fewer companies selling health insurance to big, nationwide employers that need a broad network of services.
Fewer companies usually means higher prices for these big companies, and Anthem's lawyer Christopher Curran took issue with that idea. "The notion that these Fortune 500 companies are going to be victimized here ... is not realistic," Curran said in court.
Curran also argued that the Justice Department had failed to consider the new online private exchanges where corporations allow employees to choose from multiple insurers. Continued...